A single moment of recklessness can shatter a career—and that’s exactly what happened to Spanish pro cyclist Francisco 'Kiko' Galván. But here's where it gets controversial: Was his dismissal from Kern Pharma justified, or did the team overreact to a mistake that, while dangerous, didn’t result in harm? Let’s dive into the story that’s left the cycling world divided.
Less than three months ago, a video surfaced on social media showing Galván swerving dangerously across lanes on a Barcelona road. Kern Pharma swiftly issued a statement condemning the unnamed rider’s actions, labeling them a violation of road safety regulations and promising disciplinary action. Now, Galván has confirmed he was ‘thrown off the team,’ a decision that forced him to sell his car and confront the abrupt collapse of his career. ‘I left the dealership and walked home,’ he shared on Instagram. ‘That’s when I realized how quickly everything can change.’
At just 28, Galván’s fall from grace is both poignant and polarizing. He’s been training in black clothing, not for style, but as a reflection of his inner turmoil. ‘People still recognize me, stop me, and ask questions,’ he wrote. ‘I smile, but inside, I feel ashamed—ashamed of failing my parents, my loved ones, and my girlfriend, who stood by me when everything fell apart.’ And this is the part most people miss: Behind the headlines is a human story of regret, consequence, and the struggle to rebuild.
Kern Pharma expressed ‘outrage’ over the incident, stating the rider’s actions contradicted the team’s values. Yet, the team has neither confirmed Galván’s dismissal nor named him publicly, leaving room for speculation. Cycling Weekly has reached out for comment, but the silence only fuels the debate: Did Galván deserve such a harsh penalty, or was this a case of public relations over compassion?
In his Instagram post, Galván took full responsibility for his mistake. ‘I’m not asking for pity,’ he clarified. ‘A mistake has consequences, and I’m paying for them. I apologize to everyone affected.’ He announced the end of his cycling career, not as a farewell, but as a pause—a moment to regroup and move forward ‘with my feet on the ground.’ Here’s a thought-provoking question for you: Should athletes be defined by their worst moments, or is there room for redemption after a public fall from grace?
Galván’s six seasons with Kern Pharma, which began in 2020, included highlights like his 2022 Vuelta a España participation—his only Grand Tour appearance. He also secured two podiums at the Grand Prix Cycliste la Marseillaise and a fourth-place finish at the Grote Prijs Jean-Pierre Monseré. His final race, Paris-Chauny in September, ended with a 17th-place finish—a quiet conclusion to a career cut short.
As the cycling community debates Galván’s fate, one thing is clear: his story serves as a stark reminder of the fragility of success and the weight of personal responsibility. What do you think? Was Kern Pharma’s decision fair, or did they go too far? Share your thoughts in the comments—let’s keep the conversation going.
